ArticleIndian journal of pediatrics2025
Sociodemographic and Clinical Characteristics of Rotavirus Diarrhea in Children Aged Under 5 Years in Odisha After the Introduction of Rotavirus Vaccine: A Hospital-Based Surveillance Study.
Article in Indian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Epidemiological characteristics of rotavirus among children aged 5 years and under in Zhangzhou, China, 2023-2024.BMC infectious diseases · 2026Article
- Factors Associated with Rotavirus Positivity in Children with Acute Gastroenteritis in Jharkhand, India (2019-2023).Indian journal of pediatrics · 2025Article
- Nutritional Status and Its Association with Rotavirus Positivity Among Children Aged Under 5 Years Hospitalized with Diarrhea at a Tertiary Care Center in Gujarat, India.Indian journal of pediatrics · 2025Observational
- Epidemiology of Rotavirus Gastroenteritis in Children Under Five in Maharashtra, India: A Multicenter Surveillance Study After Vaccine Introduction.Indian journal of pediatrics · 2025Article
- Strengthening Immunization Through Evidence: Lessons from ROTASIIL Implementation.Indian journal of pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesRotavirus diarrhea is a leading cause of death in children aged under 5 y. Odisha introduced Rotavac in April 2016 and switched to ROTASIIL in January 2022. This study aimed to investigate the sociodemographic and clinical characteristics of rotavirus-associated diarrhea in children aged under 5 y in Odisha after the transition to ROTASIIL.
methodsChildren aged under 5 y hospitalized with acute gastroenteritis (AGE) in four hospitals in Odisha between January and December 2023 were enrolled in this cross-sectional study. Stool samples were tested for rotavirus using an enzyme immunoassay. Clinical and demographic data were collected and analyzed according to rotavirus status.
resultsOf 365 children enrolled, 288 had their stool samples tested for rotavirus. Rotavirus was detected in 67 (23.3%) of the samples tested. The incidence of rotavirus-positive AGE was higher in boys than in girls, and rotavirus positivity was higher from November to March than during the rest of the year. Most rotavirus-positive children were of low socioeconomic status. The incidence of severe to very severe dehydration was 78% in the rotavirus-positive group compared with 69.2% in the rotavirus-negative group. No deaths were reported.
conclusionsRotavirus remains an important cause of AGE in children aged under 5 y in Odisha, despite the introduction of rotavirus vaccination. The rotavirus positivity rate was lower than that reported in previous studies, suggesting a positive effect of vaccination. High vaccination coverage, addressing poverty, and prompt clinical management are essential to mitigate the impact of rotavirus diarrhea in Odisha.
Indexed as
Identifiers
41361108What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.